跳转至内容
Merck

P2191

Sigma-Aldrich

聚(D,L-丙交酯-co-乙交酯)

lactide:glycolide (50:50), mol wt 30,000-60,000

别名:

LACTEL® B6010-2, PLGA

登录查看公司和协议定价


About This Item

线性分子式:
[C3H4O2]x[C2H2O2]y
MDL號碼:
分類程式碼代碼:
12352211
PubChem物質ID:
NACRES:
NA.25

饋電比

lactide:glycolide (50:50)

分子量

30,000-60,000

儲存溫度

−20°C

SMILES 字串

OCC(O)=O.CC(O)C(O)=O

正在寻找类似产品? 访问 产品对比指南

一般說明

聚(D,L-丙交酯-共-乙交酯)是一种可生物降解的生物相容性聚合物,可用于药物输送。它可用于治疗类风湿性关节炎、溃疡性结肠炎、克罗恩病、炎性肺病、以及眼部炎性疾病。聚(D,L-丙交酯-共-乙交酯)可作为潜在的癌症治疗靶标起作用。

應用

聚(D,L-丙交酯-共-乙交酯)已经用于在凝胶中提高和维持乳酸盐单体水平,其浓度与皮肤伤口有关。

特點和優勢

控释生物活性剂、缝线和可生物吸收植入器件。

外觀

具有生物相容性且可生物降解的聚合物。

法律資訊

Lactel is a registered trademark of Evonik Corp

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Characterization of biodegradable poly (D, L-lactide-co-glycolide) polymers and microspheres
Hausberger AG and DeLuca PP
Journal of Pharmaceutical and Biomedical Analysis, 13(6), 747-760 (1995)
PLGA-based nanoparticles: an overview of biomedical applications
Danhier F, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society, 161(2), 505-522 (2012)
Habibun Nabi et al.
Parasitology research, 116(1), 359-370 (2016-10-28)
Toxoplasmosis is one of the most common zoonotic protozoal diseases. Recent advances in biotechnology have produced recombinant protein, which are immunogenic, and progress in nano-pharmaceutics has generated encapsulated protein in nanospheres, which are suitable for vaccine delivery. DNA was extracted
Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms
Hunt TK, et al.
Antioxidants & Redox Signaling, 9(8), 1115-1124 (2007)
Ahmed A Abd-Rabou et al.
Biological trace element research, 193(2), 377-389 (2019-05-09)
Colon cancer in men and breast cancer in women are regarded as major health burdens, accounting for majority of cancer diagnoses globally. Doxorubicin (DOX) resistance in breast and colon cancers represents the main reason of unsuccessful therapy. The rationale of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门